XML 17 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common
Additional Paid‑In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2020   116,992,472      
Beginning balance at Dec. 31, 2020 $ 811,014 $ 117 $ 903,116 $ 0 $ (92,219)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares)   1,526,856      
Exercise of stock options 8,570 $ 2 8,568    
Vesting of restricted stock units (in shares)   507,776      
Issuance of common stock under the employee stock purchase plan 0        
Share‑based compensation 22,774   22,774    
Purchase of capped calls (36,030)   (36,030)    
Foreign currency translation adjustments (8,120)     (8,120)  
Net loss (51,439)       (51,439)
Ending balance (in shares) at Sep. 30, 2021   119,027,104      
Ending balance at Sep. 30, 2021 746,769 $ 119 898,428 (8,120) (143,658)
Beginning balance (in shares) at Jun. 30, 2021   118,249,912      
Beginning balance at Jun. 30, 2021 803,959 $ 118 917,116 0 (113,275)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares)   269,416      
Exercise of stock options 1,507 $ 1 1,506    
Vesting of restricted stock units (in shares)   507,776      
Share‑based compensation 15,836   15,836    
Purchase of capped calls (36,030)   (36,030)    
Foreign currency translation adjustments (8,120)     (8,120)  
Net loss (30,383)       (30,383)
Ending balance (in shares) at Sep. 30, 2021   119,027,104      
Ending balance at Sep. 30, 2021 746,769 $ 119 898,428 (8,120) (143,658)
Beginning balance (in shares) at Dec. 31, 2021   119,426,064      
Beginning balance at Dec. 31, 2021 738,426 $ 119 913,581 (7,866) (167,408)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares)   747,410      
Exercise of stock options 4,682 $ 1 4,681    
Vesting of restricted stock units (in shares)   1,036,161      
Issuance of common stock under the employee stock purchase plan (in shares)   130,450      
Issuance of common stock under the employee stock purchase plan 3,419   3,419    
Share‑based compensation 89,524   89,524    
Foreign currency translation adjustments (56,218)     (56,218)  
Net loss (120,070)       (120,070)
Ending balance (in shares) at Sep. 30, 2022   121,340,085      
Ending balance at Sep. 30, 2022 659,763 $ 120 1,011,205 (64,084) (287,478)
Beginning balance (in shares) at Jun. 30, 2022   120,310,047      
Beginning balance at Jun. 30, 2022 693,946 $ 120 987,576 (37,574) (256,176)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares)   476,637      
Exercise of stock options 3,139   3,139    
Vesting of restricted stock units (in shares)   553,401      
Share‑based compensation 20,490   20,490    
Foreign currency translation adjustments (26,510)     (26,510)  
Net loss (31,302)       (31,302)
Ending balance (in shares) at Sep. 30, 2022   121,340,085      
Ending balance at Sep. 30, 2022 $ 659,763 $ 120 $ 1,011,205 $ (64,084) $ (287,478)